Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Patient
55%
Smoking
26%
Lung
22%
Mortality
18%
Therapeutic Procedure
17%
Inpatient
14%
Asthma
12%
Forced Expiratory Volume
12%
Biological Marker
11%
Corticosteroid
10%
Age
10%
Diagnosis
10%
Association
10%
Diseases
10%
Fluticasone Furoate
9%
Hazard Ratio
8%
Deterioration
8%
Vilanterol
7%
Population
7%
Airflow
7%
Assessment
7%
Placebo
7%
Follow up
7%
Spirometry
7%
Randomized Controlled Trial
7%
Woman
7%
Eosinophil
7%
Cardiovascular Disease
6%
Emphysema
6%
Analysis
6%
All Cause Mortality
6%
Morbidity
6%
Hospital
6%
Measurement
6%
Phenotype
5%
Evaluation Study
5%
Heart Failure
5%
Prevalence
5%
Bronchodilating Agent
5%
Forced Vital Capacity
5%
Disease Exacerbation
5%
Pneumonia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
79%
Corticosteroid
15%
Placebo
15%
Mortality
13%
Biological Marker
8%
Fluticasone Furoate
8%
Pneumonia
8%
Diseases
8%
Deterioration
7%
Salmeterol
7%
Vilanterol
7%
Death
6%
Disease Exacerbation
5%
Prevalence
5%
Asthma
5%
Nursing and Health Professions
Obstructive Lung Disease
32%
Patient
14%
Mortality
6%